ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,839Medicare Part D Prescriptions Filled, Including Refills

Rank: 345 out of 2343

$508K Total Retail Price of All Prescriptions

Rank: 653 out of 2343

320 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 320 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 9,511 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 684 549 1 3
SIMVASTATIN 628 500 2 1
LEVOTHYROXINE SODIUM 539 416 3 2
OMEPRAZOLE 503 390 4 4
METFORMIN HCL 463 360 5 9
HYDROCHLOROTHIAZIDE 422 363 6 11
AMLODIPINE BESYLATE 363 320 7 5
FUROSEMIDE 346 308 8 6
METOPROLOL TARTRATE 306 275 9 7
ATENOLOL 296 254 10 12
POTASSIUM CHLORIDE 275 219 11 18
ATORVASTATIN CALCIUM 226 198 12 10
PRAVASTATIN SODIUM 225 161 13 15
GEMFIBROZIL 210 148 14 133
CARVEDILOL 197 180 15 27
WARFARIN SODIUM 187 185 16 8
CITALOPRAM HBR 185 128 17 17
ALENDRONATE SODIUM 167 135 18 28
ADVAIR DISKUS 157 128 19 34
GABAPENTIN 154 124 20 16
GLIPIZIDE 151 132 21 56
TAMSULOSIN HCL 134 130 22 29
RANITIDINE HCL 110 71 23 43
DILTIAZEM 24HR ER 105 84 24 76
LACTULOSE 99 75 25 139
DONEPEZIL HCL 97 97 26 21
ISOSORBIDE MONONITRATE ER 96 96 27 32
LANTUS 84 32 28 51
BENAZEPRIL HCL 80 67 29 113
DIGOXIN 79 79 30 35
PROAIR HFA 77 54 31 86
METOPROLOL SUCCINATE 77 77 31 14
ZETIA 75 67 33 52
ALLOPURINOL 72 60 34 31
AZITHROMYCIN 71 56 35 39
TRAZODONE HCL 68 48 36 53
CRESTOR 67 38 37 30
SINGULAIR 66 41 38 100
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 47 39 42
PAROXETINE HCL 65 40 39 66
PEN NEEDLE 63 43 41 119
CLOPIDOGREL 63 56 41 26
NIASPAN 62 40 43 141
EVISTA 61 61 44 128
LEVEMIR FLEXPEN 60 39 45 218
SPIRIVA 59 58 46 48
FLUTICASONE PROPIONATE 56 52 47 46
LIPITOR 55 48 48 78
INSULIN SYRINGE 55 25 48 102
PLAVIX 52 47 50 38
DICLOFENAC SODIUM 52 27 50 155
ENALAPRIL MALEATE 50 50 52 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.